| Primary |
| Product Used For Unknown Indication |
39.7% |
| Hypercholesterolaemia |
12.7% |
| Blood Cholesterol Increased |
11.8% |
| Hyperlipidaemia |
8.9% |
| Hypertension |
5.7% |
| Drug Use For Unknown Indication |
4.2% |
| Blood Cholesterol |
2.3% |
| Diabetes Mellitus |
1.6% |
| Coronary Artery Disease |
1.5% |
| Prophylaxis |
1.5% |
| Atrial Fibrillation |
1.3% |
| Myocardial Ischaemia |
1.3% |
| Type 2 Diabetes Mellitus |
1.2% |
| Myocardial Infarction |
1.0% |
| Dyslipidaemia |
1.0% |
| Schizophrenia |
1.0% |
| Transient Ischaemic Attack |
1.0% |
| Angina Pectoris |
0.9% |
| Cardiovascular Event Prophylaxis |
0.9% |
| Pain |
0.9% |
|
| Rhabdomyolysis |
30.2% |
| Myalgia |
13.9% |
| Pain In Extremity |
6.9% |
| Myositis |
4.6% |
| Renal Failure Acute |
4.0% |
| Drug Interaction |
3.8% |
| Pain |
3.6% |
| Tendon Rupture |
3.6% |
| Vomiting |
3.2% |
| Muscular Weakness |
3.2% |
| Interstitial Lung Disease |
2.9% |
| Weight Decreased |
2.6% |
| Myopathy |
2.5% |
| Muscle Spasms |
2.4% |
| Sleep Disorder |
2.3% |
| Nightmare |
2.2% |
| Rash |
2.2% |
| Liver Function Test Abnormal |
2.0% |
| Blood Creatine Phosphokinase Increased |
2.0% |
| Pulmonary Fibrosis |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
29.4% |
| Drug Use For Unknown Indication |
16.3% |
| Hypertension |
10.4% |
| Blood Cholesterol Increased |
7.4% |
| Hypercholesterolaemia |
5.4% |
| Hyperlipidaemia |
4.5% |
| Diabetes Mellitus |
4.0% |
| Type 2 Diabetes Mellitus |
3.8% |
| Depression |
2.7% |
| Pain |
1.8% |
| Drug Abuse |
1.8% |
| Hepatitis C |
1.7% |
| Coronary Artery Disease |
1.7% |
| Asthma |
1.5% |
| Blood Cholesterol |
1.4% |
| Atrial Fibrillation |
1.4% |
| Anxiety |
1.3% |
| Acute Coronary Syndrome |
1.2% |
| Prophylaxis |
1.2% |
| Completed Suicide |
1.1% |
|
| Rhabdomyolysis |
25.1% |
| Myalgia |
9.1% |
| Completed Suicide |
7.3% |
| Weight Decreased |
7.2% |
| Vomiting |
6.8% |
| White Blood Cell Count Increased |
5.2% |
| Pain In Extremity |
4.0% |
| Renal Failure Acute |
3.5% |
| Nausea |
3.1% |
| Pain |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Drug Interaction |
3.0% |
| Weight Increased |
3.0% |
| Rash |
2.9% |
| Oedema Peripheral |
2.6% |
| Death |
2.4% |
| Renal Failure |
2.3% |
| Liver Function Test Abnormal |
2.2% |
| Toxicity To Various Agents |
2.2% |
| Transaminases Increased |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.7% |
| Drug Use For Unknown Indication |
15.4% |
| Hypertension |
11.9% |
| Blood Cholesterol Increased |
4.6% |
| Diabetes Mellitus |
4.4% |
| Rheumatoid Arthritis |
3.6% |
| Pain |
3.1% |
| Depression |
2.9% |
| Type 2 Diabetes Mellitus |
2.6% |
| Atrial Fibrillation |
2.5% |
| Prophylaxis |
2.2% |
| Osteoporosis |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Cardiac Disorder |
1.5% |
| Blood Cholesterol |
1.5% |
| Hyperlipidaemia |
1.3% |
| Anxiety |
1.1% |
| Blood Pressure |
1.1% |
|
| Vomiting |
11.4% |
| Weight Decreased |
8.7% |
| Flushing |
6.5% |
| Drug Ineffective |
6.1% |
| Weight Increased |
5.4% |
| Nausea |
5.2% |
| Myocardial Infarction |
5.1% |
| Renal Failure Acute |
5.0% |
| Pruritus |
4.7% |
| Syncope |
4.7% |
| Death |
4.5% |
| Pneumonia |
4.3% |
| Urinary Tract Infection |
4.2% |
| Pain |
4.2% |
| Tremor |
3.6% |
| Dyspnoea |
3.6% |
| Rash |
3.5% |
| Thrombocytopenia |
3.3% |
| Renal Failure |
3.1% |
| Pain In Extremity |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
31.9% |
| Drug Use For Unknown Indication |
12.9% |
| Hypertension |
10.2% |
| Hypercholesterolaemia |
4.8% |
| Myocardial Infarction |
4.5% |
| Hyperlipidaemia |
4.2% |
| Coronary Artery Disease |
3.4% |
| Pneumonia |
3.1% |
| Myocardial Ischaemia |
2.9% |
| Blood Cholesterol Increased |
2.6% |
| Supraventricular Tachycardia |
2.6% |
| Atrial Fibrillation |
2.4% |
| Pain |
2.3% |
| Lower Respiratory Tract Infection |
2.0% |
| Prophylaxis Against Transplant Rejection |
2.0% |
| Cardiovascular Disorder |
1.8% |
| Hypertriglyceridaemia |
1.7% |
| Diabetes Mellitus |
1.7% |
| Prostate Cancer |
1.6% |
| Gastritis |
1.4% |
|
| Rhabdomyolysis |
31.9% |
| Drug Interaction |
22.8% |
| Supraventricular Tachycardia |
6.7% |
| Myopathy |
6.0% |
| Myalgia |
4.1% |
| Vomiting |
4.1% |
| Transaminases Increased |
2.8% |
| Blood Creatine Phosphokinase Increased |
2.3% |
| Myositis |
2.3% |
| Weight Decreased |
2.3% |
| Weight Increased |
1.8% |
| High Density Lipoprotein Decreased |
1.6% |
| Muscular Weakness |
1.6% |
| Myocardial Infarction |
1.6% |
| White Blood Cell Count Increased |
1.6% |
| Asthenia |
1.3% |
| Gastrointestinal Haemorrhage |
1.3% |
| International Normalised Ratio Increased |
1.3% |
| Pain In Extremity |
1.3% |
| Tremor |
1.3% |
|
